Galderma rises pre-market after Q3 beat, outlook upgrade

Galderma AG

23/10/2025 07:41

** Shares in Galderma GALD.S rise 5.6% in pre-market trade after the Swiss skincare company  Q3 sales beat and outlook upgraded its outlook

** Q3 sales were $1.29 billion compared with consensus expectations of $1.24 billion

** The company now expects FY sales to grow 17%-17.7% vs 12%-14% expected before, and core EBITDA margin of 23.1%-23.6% vs about 23% before

** "Despite Galderma having been cautious for Q3 at its 1H25 results, it delivered a strong Q3," Vontobel says

 (Reporting by Amir Orusov)

 ((Amir.orusov@thomsonreuters.com))